Wednesday, March 25, 2009

Hard to Treat Diseases (HTDS) enters Guatemala market

Hard to Treat Diseases (HTDS) is pleased to announce that Mellow Hope a subsidiary of HTDS was granted import licensing from Guatemala's Ministry of Health to import their Oral Poliomyelitis Vaccine (Brand Name: Mevac-OPV). Application has now been made to the Chinese State Food & Drug Administration (FDA) for an export license. Anticipated delivery date for the vaccine is 2nd quarter of 2009.

Terry Yuan HTDS CEO said, "Guatemala's Expanded Vaccination Program (EPI) requires for all newborns to be vaccinated. The OPV is included in this vaccination program. In 2008, the country realized a new birth rate of 380,000. Given these statistics, demand for the Mevac-OPV is expected to be extremely high".
See the rest of the story on Yahoo Finance.

No comments:

Post a Comment